Truist Financial Reaffirms Their Buy Rating on Crispr Therapeutics AG (CRSP)
Truist Financial analyst Joon Lee maintained a Buy rating on Crispr Therapeutics AG (CRSP – Research Report) today. The company’s shares closed ...
Truist Financial Reaffirms Their Buy Rating on IQVIA Holdings (IQV)
Truist Financial analyst Jailendra Singh reiterated a Buy rating on IQVIA Holdings (IQV – Research Report) today and set a price target of ...
Zacks.com on MSN3h
TFC or NTRS: Which Is the Better Value Stock Right Now?
Another notable valuation metric for TFC is its P/B ratio of 1.10. The P/B ratio is used to compare a stock's market value with its book value, which is defined as total assets minus total liabilities ...
Janney Montgomery Scott LLC Boosts Position in Donaldson Company, Inc. (NYSE:DCI)
Janney Montgomery Scott LLC raised its stake in shares of Donaldson Company, Inc. (NYSE:DCI – Free Report) by 7.3% in the ...
e.l.f. Beauty’s (ELF) “Neutral” Rating Reiterated at UBS Group
UBS Group reissued their neutral rating on shares of e.l.f. Beauty (NYSE:ELF – Free Report) in a research note published on ...
Truist raises Equitable Holdings target to $60 on growth outlook
Truist Securities updated its analysis of Equitable Holdings Inc (NYSE:EQH), increasing the price target to $60 from the ...
Truist cuts Mohawk Industries stock price target to $148
Truist Securities adjusted its outlook on Mohawk Industries (NYSE:MHK) by reducing the price target from $155.00 to $148.00, while reiterating a Buy rating on the company's shares. The adjustment ...
Insperity, Inc. (NSP) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Conference Call highlights strong financial results, strategic partnerships, and growth outlook for 2025.